BrainsWay to Report Second Quarter 2025 Financial Results on August 13, 2025
BrainsWay (NASDAQ & TASE: BWAY), a leader in noninvasive neurostimulation treatments for mental health disorders, has scheduled its second quarter 2025 financial results announcement for August 13, 2025, before U.S. markets open.
The company will host a conference call and webcast at 8:30 AM Eastern Time to discuss financial results and operational highlights. The call will be accessible via multiple dial-in numbers and will be available for replay on the company's investor relations website for 30 days.
BrainsWay (NASDAQ e TASE: BWAY), leader nei trattamenti non invasivi di neurostimolazione per disturbi mentali, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 13 agosto 2025, prima dell'apertura dei mercati statunitensi.
L'azienda terrà una conference call e una webcast alle 8:30 AM ora Eastern per discutere i risultati finanziari e i principali sviluppi operativi. La chiamata sarà accessibile tramite diversi numeri di telefono e sarà disponibile in replay sul sito web delle relazioni con gli investitori della società per 30 giorni.
BrainsWay (NASDAQ y TASE: BWAY), líder en tratamientos no invasivos de neuroestimulación para trastornos de salud mental, ha programado el anuncio de resultados financieros del segundo trimestre de 2025 para el 13 de agosto de 2025, antes de la apertura de los mercados en EE. UU.
La compañía realizará una llamada conferencia y una transmisión en vivo a las 8:30 AM hora del Este para discutir los resultados financieros y los aspectos operativos destacados. La llamada estará disponible a través de varios números de acceso y podrá escucharse en repetición en el sitio web de relaciones con inversores de la empresa durante 30 días.
BrainsWay (NASDAQ 및 TASE: BWAY)는 정신 건강 장애를 위한 비침습적 신경자극 치료 분야의 선두주자로, 2025년 2분기 재무 실적 발표를 2025년 8월 13일 미국 시장 개장 전에 예정하고 있습니다.
회사는 재무 실적 및 운영 주요 사항을 논의하기 위해 동부 표준시 기준 오전 8시 30분에 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다. 이 통화는 여러 전화 접속 번호를 통해 참여할 수 있으며, 회사 투자자 관계 웹사이트에서 30일간 다시 듣기가 가능합니다.
BrainsWay (NASDAQ et TASE : BWAY), leader dans les traitements non invasifs de neurostimulation pour les troubles de santé mentale, a programmé l'annonce des résultats financiers du deuxième trimestre 2025 pour le 13 août 2025, avant l'ouverture des marchés américains.
L'entreprise organisera une conférence téléphonique et une diffusion en direct à 8h30 heure de l'Est pour discuter des résultats financiers et des points forts opérationnels. L'appel sera accessible via plusieurs numéros d'appel et sera disponible en replay sur le site des relations investisseurs de la société pendant 30 jours.
BrainsWay (NASDAQ und TASE: BWAY), ein führendes Unternehmen für nicht-invasive Neurostimulationsbehandlungen bei psychischen Erkrankungen, hat die Veröffentlichung der Finanzergebnisse für das zweite Quartal 2025 für den 13. August 2025 vor Markteröffnung in den USA geplant.
Das Unternehmen wird um 8:30 Uhr Eastern Time eine Telefonkonferenz und Webcast abhalten, um die Finanzergebnisse und operative Highlights zu besprechen. Der Anruf ist über mehrere Einwahlnummern erreichbar und wird für 30 Tage auf der Investor-Relations-Website des Unternehmens als Aufzeichnung verfügbar sein.
- None.
- None.
BURLINGTON, Mass. and JERUSALEM, July 30, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its second quarter 2025 financial results, as well as operational highlights, before the open of the U.S. financial markets on Wednesday, August 13, 2025. The Company will host a conference call and webcast at 8:30 AM Eastern Time to discuss the results and provide an update on business operations.
Conference Call Dial-In & Webcast Information
| Date: | Wednesday, August 13, 2025 |
| Time: | 8:30 AM Eastern Time |
| United States: | 1-877-300-8521 |
| International: | 1-412-317-6026 |
| Israel: | 1-80-921-2373 |
| Conference ID: | 10201287 |
| Webcast: | Link |
The conference call will be broadcast live and will be available for replay for 30 days on the Company’s website, https://investors.brainsway.com/events-and-presentations/event-calendar. Please access the Company’s website at least 10 minutes ahead of the conference call to register.
About BrainsWay
BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives. BrainsWay is the first and only TMS company to obtain three FDA-cleared indications backed by pivotal clinical studies demonstrating clinically proven efficacy. Current indications include major depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. The Company is dedicated to leading through superior science and building on its unparalleled body of clinical evidence. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. Founded in 2003, with operations in the United States and Israel, BrainsWay is committed to increasing global awareness of and broad access to Deep TMS. For the latest news and information about BrainsWay, please visit www.brainsway.com.
Contacts:
BrainsWay:
Ido Marom
Chief Financial Officer
Ido.Marom@BrainsWay.com
Investors:
Brian Ritchie
LifeSci Advisors
britchie@lifesciadvisors.com
FAQ
When will BrainsWay (BWAY) report Q2 2025 earnings?
How can investors join BrainsWay's Q2 2025 earnings call?
Where can I access the replay of BrainsWay's Q2 2025 earnings call?
What time is BrainsWay's Q2 2025 earnings call?
